Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Summary</h2><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Genetic variation has an important role in the development of non-small-cell lung cancer (NSCLC). However, genetic factors for lung cancer have not been fully identified, especially in Chinese populations, which limits the use of existing polygenic risk scores (PRS) to identify subpopulations at high risk of lung cancer for prevention. We therefore aimed to identify novel loci associated with NSCLC risk, and generate a PRS and evaluate its utility and effectiveness in the prediction of lung cancer risk in Chinese populations.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>To systematically identify genetic variants for NSCLC risk, we newly genotyped 19 546 samples from Chinese NSCLC cases and controls from the Nanjing Medical University Global Screening Array Project and did a meta-analysis of genome-wide association studies (GWASs) of 27 120 individuals with NSCLC and 27 355 without NSCLC (13 327 cases and 13 328 controls of Chinese descent as well as 13 793 cases and 14 027 controls of European descent). We then built a PRS for Chinese populations from all reported single-nucleotide polymorphisms that have been reported to be associated with lung cancer risk at genome-wide significance level. We evaluated the utility and effectiveness of the generated PRS in predicting subpopulations at high-risk of lung cancer in an independent prospective cohort of 95 408 individuals from the China Kadoorie Biobank (CKB) with more than 10 years' follow-up.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Findings</h3><p>We identified 19 susceptibility loci to be significantly associated with NSCLC risk at p≤5·0 × 10<sup>−8</sup>, including six novel loci. When applied to the CKB cohort, the PRS of the risk loci successfully predicted lung cancer incident cases in a dose-response manner in participants at a high genetic risk (top 10%) than those at a low genetic risk (bottom 10%; adjusted hazard ratio 1·96, 95% CI 1·53–2·51; p<sub>trend</sub>=2·02 × 10<sup>−9</sup>). Specially, we observed consistently separated curves of lung cancer events in individuals at low, intermediate, and high genetic risk, respectively, and PRS was an independent effective risk stratification indicator beyond age and smoking pack-years.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Interpretation</h3><p>We have shown for the first time that GWAS-derived PRS can be effectively used in discriminating subpopulations at high risk of lung cancer, who might benefit from a practically feasible PRS-based lung cancer screening programme for precision prevention in Chinese populations.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Funding</h3><p>National Natural Science Foundation of China, the Priority Academic Program for the Development of Jiangsu Higher Education Institutions, National Key R&D Program of China, Science Foundation for Distinguished Young Scholars of Jiangsu, and China's Thousand Talents Program.</p>

Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer.

Genome-wide Association Study of Familial Lung Cancer.

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls

Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

Large-scale Association Analysis Identifies New Lung Cancer Susceptibility Loci and Heterogeneity in Genetic Susceptibility Across Histological Subtypes

Data from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

Fine Mapping Of Chromosome 6q23-25 Region In Familial Lung Cancer Families Reveals Rgs17 As A Likely Candidate Gene

A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese

Association Analyses Identify Multiple New Lung Cancer Susceptibility Loci and Their Interactions with Smoking in the Chinese Population

Genome-wide Association Analysis Identifies New Lung Cancer Susceptibility Loci in Never-Smoking Women in Asia

Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk

Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: a Pooled Analysis from the International Lung Cancer Consortium.

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Identification of Lung Cancer Histology-Specific Variants Applying Bayesian Framework Variant Prioritization Approaches Within the TRICL and ILCCO Consortia.

Family aggregation of pulmonary ground-glass nodules: Identification of multiple candidate risk loci.

Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations

Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies

Deciphering associations for lung cancer risk through imputation and analysis of 12 316 cases and 16 831 controls

Identification of Heritable Rare Variants Associated with Early-Stage Lung Adenocarcinoma Risk

High-throughput characterization of functional variants highlights heterogeneity and polygenicity underlying lung cancer susceptibility